rs2255141
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001244949.2(GPAM):c.414-283T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.77 in 152,098 control chromosomes in the GnomAD database, including 46,012 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.77 ( 46012 hom., cov: 32)
Consequence
GPAM
NM_001244949.2 intron
NM_001244949.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.190
Publications
73 publications found
Genes affected
GPAM (HGNC:24865): (glycerol-3-phosphate acyltransferase, mitochondrial) This gene encodes a mitochondrial enzyme which prefers saturated fatty acids as its substrate for the synthesis of glycerolipids. This metabolic pathway's first step is catalyzed by the encoded enzyme. Two forms for this enzyme exist, one in the mitochondria and one in the endoplasmic reticulum. Two alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.928 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.770 AC: 117043AN: 151982Hom.: 45957 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
117043
AN:
151982
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.770 AC: 117157AN: 152098Hom.: 46012 Cov.: 32 AF XY: 0.768 AC XY: 57055AN XY: 74336 show subpopulations
GnomAD4 genome
AF:
AC:
117157
AN:
152098
Hom.:
Cov.:
32
AF XY:
AC XY:
57055
AN XY:
74336
show subpopulations
African (AFR)
AF:
AC:
38873
AN:
41540
American (AMR)
AF:
AC:
10726
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
2012
AN:
3468
East Asian (EAS)
AF:
AC:
3803
AN:
5174
South Asian (SAS)
AF:
AC:
3999
AN:
4820
European-Finnish (FIN)
AF:
AC:
7049
AN:
10542
Middle Eastern (MID)
AF:
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48452
AN:
67968
Other (OTH)
AF:
AC:
1547
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1308
2617
3925
5234
6542
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2793
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.